MP Materials Rips 9% to $51 on 89% Revenue Growth — $41M EBITDA Swing Still Leaves It 48% Below $100

MP Materials closed Friday at $51.76 after trading a range of $48.17 to $52.15, an advance of 8.99% from the prior close of $47.49. That capped the stock's strongest week since September, roughly ten months. Market capitalisation sits near $9.22 billion, with trailing twelve-month EPS at negative $0.41 and beta at 1.92.

The forecast here turns on a distinction the market spent all of Thursday and Friday resolving in real time. On Thursday afternoon MP reported Q2 revenue of $108.49 million against a $95.73 million consensus — a 13.33% beat and an 89% year-over-year increase — while adjusted diluted EPS came in at negative $0.01 versus expectations for a $0.01 profit. The immediate reaction was muted: the stock closed the regular session at $47.49, down 0.88%, and barely moved after hours. Then it went up 9% the next day.

That two-day sequence is the whole story. The initial reaction priced the EPS miss. The Friday move priced what was actually in the release: adjusted EBITDA of $28.5 million, up $41.0 million year-over-year, NdPr sales volumes higher by 127%, revenue plus intangible income of $126.1 million that more than doubled, a completed first heavy rare earth separation circuit, and a new multiyear gadolinium oxide supply agreement with a U.S. aerospace and defense customer.

A company swinging $41 million of EBITDA in twelve months is not a commodity miner having a good quarter. It is an industrial buildout crossing from spending to earning.

The problem is that MP at $51.76 still sits approximately 48.4% below its 52-week high of $100.25, against a 52-week low of $37.81. The market is not disputing the operational progress. It is refusing to pay for it while capital expenditure guidance runs at $500 million to $600 million for 2026 and the magnet business has not yet booked a commercial shipment.

Everything below develops that single thesis: the commodity risk has been removed by contract, the execution risk has not, and the gap between a $51.76 share price, a $77 to $79 analyst consensus and a $30.36 intrinsic-value estimate is the widest valuation dispersion in the sector. Q4 magnet shipments resolve it.

What the Second Quarter Actually Showed: $108.49 Million and a $41 Million EBITDA Swing

The Q2 numbers deserve line-by-line treatment because the headline EPS figure obscured what happened underneath it.

Revenue came in at $108.49 million against a consensus of $95.73 million, a beat of 13.33% and an increase of 89% from the year-ago quarter. Including intangible income, revenue reached $126.1 million, more than double the prior-year figure. Adjusted EBITDA was $28.5 million, an improvement of $41.0 million year-over-year. Adjusted diluted EPS printed at negative $0.01 against a $0.01 consensus, a $0.02 shortfall.

The revenue beat was driven by volume rather than price. NdPr sales volumes rose 127% year-over-year, and NdPr production reached 840 metric tons in the quarter. That production figure is lower than the record 917 metric tons posted in Q1 2026, which was itself up 63% year-over-year, so the sequential comparison is negative even as the annual comparison is dramatic. Management guided Q3 NdPr production to exceed 1,000 metric tons.

The EBITDA swing is the number that matters most. Going from negative $12.5 million to positive $28.5 million in twelve months, on revenue of $108.49 million, implies incremental EBITDA margins well above 50% on the added volume. That is the signature of an asset with high fixed costs and substantial spare capacity — every additional ton of NdPr through Mountain Pass carries very little marginal cost. It is the single strongest argument in the bull case, because it means the operating leverage the equity story has always promised is now measurable rather than theoretical.

Set against that, the EPS miss is close to meaningless. A $0.02 shortfall on a company with $500 million to $600 million of annual capex and a business model in mid-transition tells you nothing about the trajectory. The Zacks model had flagged a negative Earnings ESP of 72.73% going into the print with a Zacks Rank of 3, so the miss was anticipated by the quantitative screens even though MP had beaten in each of the trailing four quarters with an average surprise of 144.3%.

For comparison, Q1 2026 delivered revenue of $90.65 million with a net loss near $8 million. The sequential move from $90.65 million to $108.49 million is 19.7% growth in one quarter. That pace is the reason Friday happened.

The Balance Sheet Is the Reason This Buildout Is Credible

Capital adequacy is the variable that separates MP from every other name in the rare earth complex, and the Q2 disclosure settles the question for the next several years.

The company reported $1.45 billion in cash at quarter end. That compares with $1.7 billion at the end of Q1 2026, so the quarter consumed roughly $250 million of net liquidity while capital expenditure guidance for the full year was maintained at $500 million to $600 million.

Run the arithmetic. At the midpoint of guidance, MP will spend approximately $550 million on capital projects during 2026. Against $1.45 billion of cash and an EBITDA line that has just turned positive at $28.5 million per quarter and is scaling, the company can fund roughly two and a half years of construction at the current burn rate without accessing capital markets. Add the Q3 volume guidance of over 1,000 metric tons of NdPr and the associated EBITDA contribution, and the runway extends further.

That matters because the alternative — equity issuance into a stock trading 48% below its high — would be value-destructive and the market knows it. Companies in capital-intensive buildouts get repriced violently when funding risk appears. MP's $1.45 billion removes that risk from the near-term forecast, and its absence is part of why the stock found a floor at $37.81 rather than continuing lower.

The capex itself is where the money goes and it is worth naming. Construction has begun at the 10X facility, a $1.3 billion magnet plant the company internally refers to as Project Swarm. The first heavy rare earth separation circuit at Mountain Pass has been completed, with terbium and dysprosium production expected to begin later this year. Management said it plans to break ground during August on an expanded Mountain Pass area intended to house magnet recycling along with additional heavy rare earth separation and finishing capacity. A samarium programme targets first production in 2028, and a gadolinium separation project is moving into engineering and procurement on a similar timeline.

Five simultaneous construction programmes on a $9.22 billion market capitalisation is aggressive. It is also what a company does when it has contracted demand and a policy deadline. The question for the forecast is not whether MP can afford it. It is whether the projects land on schedule.

The Department of Defense Partnership Removed the Commodity Risk Entirely

The structural fact that reframes MP from a mining equity into something closer to a regulated industrial is the July 2025 public-private partnership, and its terms are more consequential than most valuation work reflects.

The U.S. Department of Defense committed $400 million through a preferred equity investment, taking a 15% stake in the company. It was the first time the department had taken equity in a critical minerals business. The package included a ten-year NdPr magnet offtake contract carrying price floor protections, and it was structured to support commissioning of heavy rare earth separation at Mountain Pass. The announcement triggered a 60% intraday surge and the stock subsequently gained more than 100%.

The price floor is the part that changes the analysis. Rare earth equities have historically traded as leveraged bets on NdPr oxide pricing, which China effectively sets through its control of roughly 80% of global processing capacity. That made every discounted cash flow model a guess about Beijing's production policy. A contractual floor on a ten-year offtake removes the downside tail from a defined portion of volume, which converts a commodity revenue line into something closer to a contracted one.

Bank of America's reaction quantified the shift when it raised its target to $78 from $42 following the announcement, citing three specific adjustments: a 33% increase in its forecast domestic realised NdPr price for MP, an assumption of fewer oxide sales to China, and an increased contribution from magnet sales. That is a research desk rebuilding a model around policy-set pricing rather than spot pricing.

The strategic footprint has since widened. MP entered a binding joint venture with the U.S. Department of War and Saudi Arabia's Maaden to develop a rare earth refinery in the Kingdom, extending refining capacity beyond U.S. borders while remaining aligned with American supply chain objectives.

The forecast consequence is that MP's revenue quality is now materially higher than its financial statements suggest. Contracted cash flows from General Motors, Apple and the Department of War underpin the model, and management cited exactly those relationships when analysts pressed on hiring difficulty for engineers and construction workers in a tight labour market. What remains uncertain is volume and timing, not price. That is a fundamentally different risk profile from the one the 1.92 beta implies.

General Motors, Apple and the January 1, 2027 Deadline

The demand side is contracted and the contracts have dates attached, which gives this forecast a harder catalyst calendar than most equity stories carry.

General Motors signed first, in 2022, with deliveries beginning in March 2025. MP now sits at the core of the automaker's domestic EV supply chain. Apple followed with a $500 million agreement in July 2025. During Q2, the Independence facility in Fort Worth delivered magnets to General Motors for in-vehicle qualification and regulatory testing, and the company continues to expect initial commercial shipments in the fourth quarter.

That Q4 date is the single most important item in the forecast. MP made its first commercial rare earth magnets at Independence in December 2025, and the Magnetics segment generated $21.1 million of revenue in Q1 2026, four times the prior-year figure. But qualification deliveries are not commercial shipments, and the market has been unwilling to capitalise magnet revenue that has not yet appeared in a customer purchase order at scale.

The policy deadline is what makes slippage expensive. A federal requirement takes effect January 1, 2027 banning Chinese critical minerals from defense supply chains, and the administration has signed an executive order making it harder for defense contractors to obtain waivers permitting purchases of Chinese critical minerals. Roughly 70% of U.S. rare earth imports have originated from China. That combination creates a hard demand wall on a fixed date, and MP owns the only rare earth mining and processing site of scale in North America.

For the stock, the deadline functions as both catalyst and risk. If Q4 commercial shipments land on schedule, MP enters 2027 as the qualified domestic supplier into a market where the alternative has been legislated out for defense applications. That is the scenario supporting the $77 to $79 consensus target. If shipments slip to Q1 or Q2 2027, the company misses the window during which its competitive position is strongest, and the equity re-rates lower on execution rather than on demand.

Management's language on the call — that demand continues to outpace production growth — is consistent with a supply-constrained business rather than a demand-constrained one. That is the right problem to have. It is also the problem that gets solved by construction schedules, not by sales effort.

Heavy Rare Earths Are the Underappreciated Part of the Quarter

The heavy rare earth progress disclosed in Q2 received less attention than the revenue beat and probably matters more to the terminal value.

MP completed its first heavy rare earth separation circuit during the quarter and expects to begin producing terbium and dysprosium later this year. It also secured a sizable multiyear gadolinium oxide supply agreement with a U.S. aerospace and defense customer, which the chief executive characterised as being at attractive economics. Management said the separation circuit was designed to process third-party feedstocks, and that it is evaluating opportunities across other rare earths contained in the Mountain Pass ore body including yttrium.

Three points follow.

First, heavies are where the economics are. Terbium and dysprosium are the additives that give NdFeB magnets high-temperature performance, which is what defense and traction motor applications require. They command multiples of NdPr pricing and China's processing dominance in heavies is even more complete than in lights. A domestic producer of terbium and dysprosium is not competing on cost — it is supplying a category where the alternative is a single-country chokepoint.

Second, the gadolinium agreement is a template rather than a one-off. Signing a multiyear supply contract with a new aerospace and defense customer for a heavy rare earth product, before the separation capacity is fully commissioned, demonstrates that customers will contract forward on capacity that does not yet exist. That is the strongest possible signal about the demand environment, and it is why the company is progressing a gadolinium separation project into engineering and procurement alongside a samarium programme targeting 2028.

Third, third-party feedstock processing converts MP from a producer into infrastructure. If the separation circuit can toll-process concentrate from other miners, MP captures a fee stream from every Western rare earth project that reaches production without building its own separation capacity. Given that separation is the actual bottleneck in the non-Chinese supply chain rather than mining, that optionality is worth real money and appears in no consensus model.

None of this contributes revenue in 2026. All of it explains why the sell-side fair value estimates cluster near $80 while the stock trades at $51.76 — the analysts are capitalising a 2028 to 2030 business and the market is pricing 2026 cash flow.

The 48% Drawdown From $100.25 Is the Central Question

Any honest forecast has to explain why a company executing this well trades less than half its high, and the answer is not that the market has missed something.

The 52-week range runs from $37.81 to $100.25. At $51.76, MP sits 48.4% below the high and 36.9% above the low. The stock is up roughly 9% in a week and has spent most of 2026 well below its January levels, having been up 16.3% year-to-date at the end of January before giving most of that back. One measure put the trailing twelve-month return at negative 23% while the S&P 500 gained 19% over the same period.

Three mechanical causes explain the drawdown.

The first is that the $100.25 high was set on policy euphoria rather than earnings. The Department of Defense equity stake produced a 60% intraday move and a subsequent doubling. Prices established by a step-change in narrative rather than a step-change in cash flow tend to retrace when the narrative stops being new, and that is what happened through the spring.

The second is competitive dilution of the thesis. USA Rare Earth announced a letter of intent for a potential $1.6 billion investment from the administration, which immediately raised the question of whether MP's position as the designated national champion was exclusive. Government support for a sector is bullish for the sector. Government support for multiple companies in a sector is not unambiguously bullish for any one of them.

The third is China's direct response. Beijing imposed export controls specifically targeting MP Materials in June, which complicates the company's ability to sell oxide into the largest processing market while its own downstream capacity is still being built.

Layer on capital intensity. A company guiding $500 million to $600 million of capex against $108.49 million of quarterly revenue is spending more than a full year of revenue on construction annually. Equity markets discount that heavily regardless of the eventual return, and the 1.92 beta reflects how violently the stock trades around every datapoint that touches the schedule.

The drawdown is rational. Whether it is excessive is the question the next two quarters answer.

Analyst Targets Run From $60 to $100 and That Dispersion Is the Signal

The sell-side picture is unusually informative because the disagreement is about model structure rather than about direction.

Eighteen analysts covering the stock produce a consensus rating of Strong Buy with an average twelve-month target between $77.47 and $79.22, implying upside near 50% from $51.76. The high estimate is $100 and the low is $61 — meaning even the most bearish covering analyst sees 18% upside. That is a rare configuration.

The recent revisions tell a more nuanced story than the average. JPMorgan's Bill Peterson lowered the firm's target to $60 from $75 on July 29 while maintaining an Overweight rating. Deutsche Bank cut to $61 from $70 on July 9. Barclays trimmed to $65 from $69 with Overweight intact. Morgan Stanley moved the other way, raising to $71.50 from $70 on July 8. Post-earnings, BMO Capital reiterated Buy and a separate desk reiterated Buy with an $82 target unchanged. Needham initiated at Buy with an $81 objective, with analyst Carter Goman framing the sector as being in the early stages of a multi-year investment cycle and describing MP as the most credible company in the race to build rare earth capacity outside China. Goldman Sachs and Bank of America both carry Buy ratings, the latter with a $78 target.

The pattern is consistent: ratings held, targets trimmed. That is what happens when analysts still believe the thesis but push their revenue recognition assumptions to the right. Cutting a target from $75 to $60 while staying Overweight is a timing revision, not a thesis revision.

The genuine bear case sits outside the covering universe. GF Value places MP's intrinsic value at $30.36, flagging the stock as substantially overvalued at current prices. Against a $51.76 share price and a $79.22 average target, that is a spread from $30 to $100 — a 3.3x range on the same company. Independent modelling has produced fair values near $80.44 with justified targets as high as $97.81.

One datapoint deserves weight against the bulls. Insider transactions showed approximately $70.7 million of stock sales against $1 million of purchases over a recent three-month window. Management selling into strength while telling investors the demand environment outpaces production is a tension worth noting rather than explaining away.

Mountain Pass Is the Asset That Cannot Be Replicated Quickly

The competitive moat is geological and it deserves precise statement because it is what justifies any premium multiple.

Mountain Pass, in San Bernardino County, California, is the only rare earth mining and processing site of scale in North America and represents the largest rare earth deposit outside China. From the 1960s through the 1980s it supplied most of the world's rare earth elements. MP Materials, founded in 2017 by James Litinsky and Michael Rosenthal and headquartered in Las Vegas, operates it through the Materials segment alongside the Magnetics segment that runs Independence in Fort Worth. The company employs 998 people.

Q1 2026 output demonstrates the asset's capability: record NdPr production of 917 metric tons, up 63% year-over-year, and record rare earth oxide concentrate production of 12,983 metric tons, up 6% on improved recoveries and operational efficiencies. Materials segment revenue climbed 30% to $72.2 million while Magnetics contributed $21.1 million.

The strategic point is about replacement time rather than resource size. A new rare earth mine requires permitting, construction and commissioning on a horizon measured in years, and separation capacity is harder still. Needham's framing of MP as significantly advantaged relative to new entrants rests on exactly this: Mountain Pass is producing today and its early move into downstream manufacturing means the bottleneck stages are already under construction rather than under study.

The peer set illustrates the gap. Lynas Rare Earths runs an integrated business from Mt Weld in Western Australia through a Malaysian advanced materials facility, generating A$715.89 million of revenue with a market capitalisation near A$16.4 billion and recent earnings growth of 62% — a genuinely comparable operator, but one facing fresh political scrutiny in Malaysia over Pentagon-related supply. USA Rare Earth, Critical Metals, Energy Fuels and NioCorp are earlier-stage. MP's $9.22 billion capitalisation places it among the larger pure-play rare earth names globally.

For the forecast, the moat supports a floor rather than a target. Scarcity value is why $37.81 held. Converting scarcity into cash flow is what takes the stock to $77.